Tylenol Levels in Bariatric Patients

NCT02982928 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 11

Last updated 2019-06-19

Study results available
· View outcomes & findings →

Summary

The current study is designed to measure and evaluate the pharmacokinetic profiling of acetaminophen in the young obese patient population.

Conditions

Sponsors & Collaborators

  • Nationwide Children's Hospital

    lead OTHER

Principal Investigators

  • Ahsan Syed, MD · Nationwide Children's Hospital

Eligibility

Min Age
12 Years
Max Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-03-06
Primary Completion
2018-01-22
Completion
2018-01-22

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02982928 on ClinicalTrials.gov